<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Thomas Flaig, MD, on Novel Combination Therapy for Advanced Urothelial Cancer

by MedPage Today | November 7, 2022
placeholder

In the following interview, co-author Thomas Flaig, vice chancellor for research for the University of Colorado Denver and the Anschutz Medical Campus in Aurora, discussed details of the study and the drug combination.

Topics: Press Coverage